DK272189D0 - Hepatitiv b virus protein, fremgangsmaade til fremstilling deraf og midler til brug ved fremstilling - Google Patents

Hepatitiv b virus protein, fremgangsmaade til fremstilling deraf og midler til brug ved fremstilling

Info

Publication number
DK272189D0
DK272189D0 DK272189A DK272189A DK272189D0 DK 272189 D0 DK272189 D0 DK 272189D0 DK 272189 A DK272189 A DK 272189A DK 272189 A DK272189 A DK 272189A DK 272189 D0 DK272189 D0 DK 272189D0
Authority
DK
Denmark
Prior art keywords
hepatitive
procedures
preparing
preparation
virus protein
Prior art date
Application number
DK272189A
Other languages
English (en)
Other versions
DK272189A (da
Inventor
Peter J Kniskern
William J Miller
Ronald W Ellis
Arpi Hagopian
Shigeko Yamazaki
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of DK272189D0 publication Critical patent/DK272189D0/da
Publication of DK272189A publication Critical patent/DK272189A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • G01N33/5761—Hepatitis B
    • G01N33/5764—Hepatitis B surface antigen
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Urology & Nephrology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Hematology (AREA)
  • General Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Communicable Diseases (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
DK272189A 1988-06-03 1989-06-02 Hepatitiv b virus protein, fremgangsmaade til fremstilling deraf og midler til brug ved fremstilling DK272189A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US20276488A 1988-06-03 1988-06-03

Publications (2)

Publication Number Publication Date
DK272189D0 true DK272189D0 (da) 1989-06-02
DK272189A DK272189A (da) 1989-12-04

Family

ID=22751163

Family Applications (1)

Application Number Title Priority Date Filing Date
DK272189A DK272189A (da) 1988-06-03 1989-06-02 Hepatitiv b virus protein, fremgangsmaade til fremstilling deraf og midler til brug ved fremstilling

Country Status (11)

Country Link
EP (1) EP0344864A3 (da)
JP (1) JPH02150292A (da)
KR (1) KR900000091A (da)
AU (1) AU616976B2 (da)
DK (1) DK272189A (da)
FI (1) FI892683A (da)
IL (1) IL90408A0 (da)
NO (1) NO892269L (da)
NZ (1) NZ229260A (da)
PT (1) PT90690A (da)
ZA (1) ZA894182B (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE207535T1 (de) * 1987-06-22 2001-11-15 Medeva Holdings Bv Hepatitis-b-oberflächenantigen enthaltendes peptid
CA2022108A1 (en) * 1989-07-31 1991-02-01 Cheryl A. Schulman Enhanced growth and expression of heterologous proteins in recombinant hosts containing mutations in cell wall and/or plasma membrane biosynthesis
EP0491077A1 (en) * 1990-12-19 1992-06-24 Medeva Holdings B.V. A composition used as a therapeutic agent against chronic viral hepatic diseases
JP3026029B2 (ja) * 1991-04-26 2000-03-27 財団法人阪大微生物病研究会 組換え水痘ウイルスとその作製法
CA2067003A1 (en) * 1991-04-29 1992-10-30 Peter J. Kniskern Hbsag escape mutant vaccine
IL101651A0 (en) * 1991-04-29 1992-12-30 Merck & Co Inc Hepatitis b virus surface proteins with reduced host carbohydrate content
IL101653A0 (en) * 1991-04-29 1992-12-30 Merck & Co Inc Multiple hepatitis b virus surface proteins which form particles
EP0533263A3 (en) * 1991-09-20 1994-06-08 Merck & Co Inc A multivalent hepatitis b virus vaccine
DE4301904A1 (de) * 1992-08-07 1994-02-10 Boehringer Mannheim Gmbh Hypoglycosylierte recombinante Glucoseoxidase
DE4301932A1 (de) * 1992-08-07 1994-02-10 Boehringer Mannheim Gmbh Hefewirtsstämme mit Defekten in der N-Glycosylierung

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU584580B2 (en) * 1982-09-08 1989-06-01 Smith Kline - Rit Hepatitis B virus vaccine
EP0401941A3 (en) * 1984-07-11 1991-04-17 Takeda Chemical Industries, Ltd. Hepatitis b virus surface antigen and production thereof
DE3537176C2 (de) * 1984-10-18 1994-06-09 Zymogenetics Inc Gewebeplasminogenaktivator und Verfahren zu seiner Herstellung
JPS61158798A (ja) * 1984-12-28 1986-07-18 Japan Found Cancer Res Ｂ型肝炎ウイルス表面抗原の製造法
WO1988006185A1 (en) * 1987-02-11 1988-08-25 Scripps Clinic And Research Foundation Retroviral expression vectors and methods for producing hbv antigens
AU619753B2 (en) * 1987-06-22 1992-02-06 Medeva Holdings B.V. Hepatitis b surface antigen vaccine

Also Published As

Publication number Publication date
FI892683A (fi) 1989-12-04
NZ229260A (en) 1994-02-25
DK272189A (da) 1989-12-04
PT90690A (pt) 1989-12-29
NO892269L (no) 1989-12-04
AU616976B2 (en) 1991-11-14
FI892683A0 (fi) 1989-06-01
EP0344864A2 (en) 1989-12-06
JPH02150292A (ja) 1990-06-08
KR900000091A (ko) 1990-01-30
NO892269D0 (no) 1989-06-02
EP0344864A3 (en) 1990-09-12
AU3597089A (en) 1989-12-07
ZA894182B (en) 1990-02-28
IL90408A0 (en) 1990-01-18

Similar Documents

Publication Publication Date Title
DK623087D0 (da) Laegemiddelpraeparat og catecholderivater til brug ved fremstilling deraf
NO893678L (no) Cyklosporinholdige preparater og fremgangsmaate for deres fremstilling.
NO900577D0 (no) Cyklosporinholdige preparater og fremgangsmaate for deres fremstilling.
DK142485D0 (da) Acyltripeptider, mellemprodukter ved deres fremstilling og farmaceutiske praeparater
DK374389A (da) Arylbenzenoxazolidinoner, deres fremstilling og anvendelse
DK40484D0 (da) Polysaccharid/protein-konjugat,fremgangsmaade til fremstilling deraf og dets anvendelse i en vaccine
NO894266L (no) Oftalmiske preparater og fremgangsmaate for deres fremstilling.
NO900469D0 (no) Piperidinforbindelser, deres fremstilling og anvendelse.
IL93957A0 (en) Bordetella outer membrane proteins,their use in vaccines and their expression
DK272189D0 (da) Hepatitiv b virus protein, fremgangsmaade til fremstilling deraf og midler til brug ved fremstilling
DK266387D0 (da) Fremgangsmaade til fremstilling af pindeunderstoettede produkter, isaer spiseis, form til brug ved udoevelse af fremgangsmaaden og pindeunderstoettede produkter opnaaet ved udoevelse af fremgangsmaaden
DK388989A (da) Acylcyanoguanidiner, deres fremstilling og anvendelse
DK435289A (da) Piperazindioner, deres fremstilling og anvendelse
NO902248L (no) Renininhiberende peptider, deres fremstilling og anvendelse i legemidler.
DK489689D0 (da) 4-nitrophenyldihydropyridinamider og fysiologisk uskadelige salte deraf, deres anvendelse og mellemprodukter ved deres fremstilling
NO890816D0 (no) De-emulgeringsblandinger og fremgangsmaate ved fremstilling og anvendelse derav.
DK703588A (da) Pai-1-blokerende peptider, deres fremstilling og anvendelse
NO901087D0 (no) Keramiske roer og fremgangsmaate ved deres fremstilling.
DK185489A (da) Imidazolylmethyl-cycloalkanoebaaindoloner, deres fremstilling og anvendelse
DK592389D0 (da) Penemderivater, deres fremstilling og anvendelse
DK266187D0 (da) Rekombinant humant protein s, fremgangsmaade til fremstilling heraf og rekombinant dna-vektor til brug ved fremgangsmaaden
NO892670L (no) Gassrensemasser og fremgangsmaate for deres fremstilling.
NO874656D0 (no) Kosmetiske preparater og fremgangsmaate ved deres fremstilling.
DK82589A (da) Piperidinforbindelser, deres fremstilling og anvendelse
NO920364D0 (no) Riboflavinblanding og fremgangsmaate ved fremstilling derav

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment